Invention Grant
- Patent Title: CDK9 inhibitors and polymorphs thereof for use as agents for treatment of cancer
-
Application No.: US18054435Application Date: 2022-11-10
-
Publication No.: US12077554B2Publication Date: 2024-09-03
- Inventor: Adam Siddiqui-Jain , Paul Flynn , Yuji Fujiwara , Shuji Masumoto , Hiroaki Tanaka , Hirotaka Kurebayashi , Takahiko Hashizuka , Yuka Arikawa
- Applicant: Sumitomo Pharma Oncology, Inc.
- Applicant Address: US MA Marlborough
- Assignee: Sumitomo Pharma Oncology, Inc.
- Current Assignee: Sumitomo Pharma Oncology, Inc.
- Current Assignee Address: US MA Marlborough
- Agency: Hamilton, Brook, Smith & Reynolds, P.C.
- Main IPC: A61P35/00
- IPC: A61P35/00 ; A61K9/00 ; C07F9/6558
Abstract:
A crystalline form and/or polymorph of a compound having the following structure (I), including tautomeric and zwitterionic forms thereof, are provided:
Methods associated with preparation and use of the polymorphs, and pharmaceutical compositions comprising the same are also provided. Also provided are methods for preparing a compound having formula (I), or a salt, tautomer or zwitterionic form thereof.
Methods associated with preparation and use of the polymorphs, and pharmaceutical compositions comprising the same are also provided. Also provided are methods for preparing a compound having formula (I), or a salt, tautomer or zwitterionic form thereof.
Public/Granted literature
- US20230250116A1 CDK9 Inhibitors and Polymorphs Thereof For Use As Agents For Treatment of Cancer Public/Granted day:2023-08-10
Information query
IPC分类:
| A | 人类生活必需 |
| A61 | 医学或兽医学；卫生学 |
| A61P | 化合物或药物制剂的特定治疗活性 |
| A61P35/00 | 抗肿瘤药 |
